MD
Madrigal Pharmaceuticals Inc.
MDGL · Madrigal Pharmaceuticals Inc. · Healthcare
Up next day
4/12
33%
Fell despite growth
4/12
Good earnings ignored
Avg earnings move
±5.4%
typical swing on earnings
Price when beating
+1.7%
avg over 7 beats
Biggest single move
+23.2%
'24.9 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Tends to run up in the week before earnings
Rose beforehand 8 of last 12 · avg +3.9% · expectations build early
Even strong results barely move the stock
Up the next day 2 of 7 beats (29%)
Reaction is erratic and hard to predict
Avg +1.7% on a beat, -0.4% on a miss
Big earnings-day moves tend to fade within days
Reversed the day-one move · 67% of last 12
vs Healthcare sector avg (153 peers)
This
+0.8%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
This stock reacts more to guidance & expectations than the reported number
Moved opposite to results 7 of last 12 times (58%)
5xBeat but fell
Even a beat sells off if guidance disappoints
2xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 4Before open
'26.9 expectedEst. EPS $-1.09
Quarter ended 6/2026
Reported 2026-07-30
Next-day move
-5.2%
After 5 days +3.5%
vs Consensus$-2.23→$-1.99+10.8% beat
Beat by +10.8% but stock -5.2%
EPS
$-1.99
YoY -5%
Revenue
$0.4B
YoY +71%
Next-Q guidance
—
N/A
Price around earnings
vs market -6.0%p
Earnings trend · last 12 quarters
EPS$-1.99YoY -5%
'23.9'26.6
Revenue$0.4BYoY +71%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
3x25%
Met expectations
good · up ↑
1x8%
Disappointment
weak · down ↓
3x25%
Good earnings ignored
good · down ↓
5x42%
← ← Weak earningsStrong earnings → →
Even on good earnings, the price often fell — earnings poorly reflected · 5 of 12q (42%)
Community · MDGL
What do you think of this stock's earnings pattern?
···